Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis

Cancer

Volumn 78, Issue 9, 1996, Pages 1958-1966

  Kuczyk, Markus A ^a   Serth, Jürgen ^a   Bokemeyer, Carsten ^b   Jonassen, Jens ^a   Machtens, Stephan ^a   Werner, Martin ^a   Jonas, Udo ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c NONE

Author keywords

genetic alteration; p53 tumor suppressor gene; testicular cancer; testicular carcinoma in situ

Indexed keywords

ALKALINE PHOSPHATASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CARCINOMA IN SITU; CLINICAL ARTICLE; DNA SEQUENCE; ENZYME ACTIVITY; GENE LOCUS; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STEM CELL; TESTIS CANCER; TUMOR SUPPRESSOR GENE;

ALKALINE PHOSPHATASE; CARCINOMA IN SITU; DNA, NEOPLASM; GENES, P53; GERMINOMA; HUMANS; ISOENZYMES; MALE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0029804942     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961101)78:9<1958::AID-CNCR17>3.0.CO;2-X     Document Type: Article

References (22)

1. Quinlan DC, Davidson AG, Sumers CL, Warden HE, Doshi HM. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 1992;52:4828-31.
2. Thor AD, Moore DH, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, et al. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 1992;84:845-54.
3. Bartkova J, Bartek I, Lukas J, Vojtesek B, Staskova Z, Reijthar A, et al. p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia. Int J Cancer 1991;49:196-202.
4. Lewis DJ, Sesterhenn IA, McCarthy WF, Mould JW. Immunohistochemical expression of p53 tumor suppressor gene protein in adult germ cell testis tumors: clinical correlation in stage 1 disease. J Urol 1994;152:418-23.
5. Fleischhacker M, Strohmeyer T, Imai Y, Slamon DJ, Koeffler HP. Mutations of the p53 gene are not detectable in human testicular tumors. Mod Pathol 1994;7:435-9.
6. Peng H-Q, Hogg D, Malkin D, Bailey D, Gallie BL, Bulbul M, et al. Mutations of the p53 gene do not occur in testis cancer. Cancer Res 1993;53:3574-8.
7. Wei YD, Jiafu Z, Xi QS, Yongjiang MA, Xiulong Z, Daizong L, et al. P53 gene mutations in Chinese human testicular seminoma. J Urol 1993; 150:884-6.
8. Schenkman NS, Sesterhenn IA, Washington L, Tong YA, Weghorst CM, Buzard GS, et al. Increased p53 protein does not correlate to p53 gene mutations in microdissected human testicular germ cell tumors. J Urol 1995;154:617-21.
9. Skakkebaek NE. Possible carcinoma-in-situ of the testis. Lancet 1972;2:516-7.
10. Kuczyk MA, Serth J, Bokemeyer C, Allhoff EP, Jonassen J, Kuczyk S, et al. Overexpression of the p53 oncoprotein in carcinoma in situ of the testis. Pathol Res Pract 1994; 190:993-8.
11. Burke AP, Mostofi FK. Placental like alkaline phosphatase immunohistochemistry of intratubular malignant germ cells and associated testicular germ cell tumors. Hum Pathol 1988;19:663-70.
12. Serth J, Kuczyk MA, Derendorf L, Jonassen J, Allhoff EP, Jonas U. Identification of frequent p53 gene alterations in testicular cancer by in situ molecular genetic and immunohistochemical analysis. J Urol 1994;151 (part 2):408A.
13. Danenberg PV, Horikoshi T, Volkenandt M, Danenberg K, Lenz H-J, Shea LCC, et al. Detection of point mutations in human DNA by analysis of RNA conformation polymorphism(s). Nucleic Acids Res 1992;20:573-9.
14. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54:4855-78.
15. Starzynska T, Bromley M, Ghosh A, Stern PL. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 1992;6:558-62.
16. Smith HS. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 1992;84:845-54.
17. Hongyo T, Buzard GS, Calvert RJ, Weghorst CM. "Cold SSCP": a simple, rapid and non-radioactive method for optimizing single-strand conformation polymorphism analyses. Nucleic Acids Res 1993;21:3637-42.
18. Dieckmann K-P, Loy V, Huland H. Das Carcinoma in situ des Hodens: klinische Bedeutung, Diagnose und Therapie. Urologe A 1989;28:271-80.
19. Giwercman A, Muller RJ, Skakkebaek NE. Carcinoma in situ of the undescended testis. Semin Urol 1988;6:110-9.
20. Skakkebaek NE, Berthelsen J, Giwercman A, Muller J. Carcinoma in situ of the testis possible origin from gonocytes and precursor of all types of germ cell tumors except spermatocytoma. Int J Androl 1987;10:19-28.
21. Atkin NB, Baker MC. Specific chromosome change, i(12p), in testicular tumours. Lancet 1982;2:1349.
22. Heidenreich A, Zumbe J, Engelmann U. Diagnosis and follow-up of testicular carcinoma in situ by DNA image cytometry. Eur Urol 1995;28:13-8.